Key facts
- This page summarizes Spiros Jamas's Form 4 filing for Entera Bio Ltd. (ENTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jan 2022, 15:19.
Spiros Jamas - 18 Jan 2022 Form 4 Insider Report for Entera Bio Ltd. (ENTX)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- ENTX
- Reported as of
- 18 Jan 2022
- Net transaction value
- +$28,500
- SEC form
- 4
- Accepted by SEC
- 24 Jan 2022, 15:19:12 UTC
- Prior SEC filing
- 24 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dana Yaacov-Garbeli, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Spiros Jamas filed Form 4 for Entera Bio Ltd. (ENTX) on 24 Jan 2022.
Change
- Previous filing in this sequence was filed on 24 Jan 2022.
- Current net transaction value: +$28,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENTX
transaction
Ordinary Shares, par value NIS 0.0000769 per share
Purchase
- Transaction value
- $28,500
- Shares
- +10,000
- Change %
- Price
- $2.85
- Shares after
- 10,000
- Date
- 18 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.84 to $2.98, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.